Form 4: Sarepta Therapeutics COO Reports Stock Transaction
Insider Transaction (Form 4)
Ian Michael Estepan, Chief Operating Officer of Sarepta Therapeutics, Inc., reported a transaction in 24,799 shares of common stock on September 4, 2026.
Summary
- Tax/exercise-price withholding: disposed of 24,799 Common Stock at $22.22 ($551,034) on September 4, 2026; holds 177,184 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ian Michael Estepan — Officer (Chief Operating Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Tax/exercise-price withholding | Common Stock | 24,799 | $22 | $551.0K | 177,184 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Tax/exercise-price withholding (24,799 shares) |
Keywords
insider transaction, Form 4, SRPT, Sarepta Therapeutics, Inc., neutral, Ian Michael Estepan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.